Features of Legal Regulation of the Names of Biomedical Cell Products
( Pp. 55-59)

More about authors
Davidenko Anastasia Olegovna рostgraduate student of the Department of Civil Law and Procedure
Academy of Labor and Social Relations
Moscow, Russian Federation
For read the full article, please, register or log in
Today, the rapid development of science and technology has led to the development of new, completely different technologies, different from traditional ones. First, it affected the sphere of biotechnology. A lot of research is being done to create biomedical cell products. However, the introduction of such products into production and their practical application involves a number of legal issues, including the naming of biomedical cell products. The relevance of the topic of this study is because in the Russian Federation, the legal regulation of BMCP is at an early stage, but this issue is of great importance for the introduction of such products and their certification on the market. The purpose of the study is to consider the features of the legal regulation of the names of biomedical cell products. Research methodology: analysis of the legal regulation of the names of biomedical cell products. The novelty of the study lies in the consideration of the features of the legal regulation of the names of biomedical cell products
How to Cite:
Davidenko A.O., (2022), FEATURES OF LEGAL REGULATION OF THE NAMES OF BIOMEDICAL CELL PRODUCTS. Sociopolitical Sciences, 2: 55-59. DOI: 10.33693/2223-0092-2022-12-2-55-59
Reference list:
Federal Law No. 180-FZ of 26.06.2016 “On biomedical cell products” [Electronic resource]. URL:http://pravo.gov.ru/proxy/ips/?docbody=&nd=102402596
Decree of the Government of the Russian Federation of 28.12.2012 No. 2580-r “Strategy for the development of medical science for the period up to 2025” [Electronic resou- rce]. URL:https://minzdrav.gov.ru/ministry/61/23/stranitsa-967/strategiya-razvitiya-meditsinskoy-nauki-v-rossiyskoy-federatsii-na-period-do-2025-goda
Bolshakova O.B. Features of the production and registration of BMCP in Russia. Bulletin of the Russian Scientific Center of Radiology of the Ministry of Health of Russia. 2021. Vol. 21. No. 2. Pp. 1-24. (In Rus.)
Ivanov D.V., Chabanenko A.V. The law on cellular products: breakthrough or defeat? Bulletin of New Medical Technologies. 2017. Vol. 24. No. 4. Pp. 166-176. (In Rus.)
More than 30 biomedical cell products are ready for registration [Electronic resource]. URL:https://ria.ru/science/20161228/1484843065.html
The Ministry of Health has authorized a clinical trial of the first BMCP in Russia [Electronic resource]. URL:https://pharmprom.ru/minzdrav-razreshil-provedenie-klinicheskogo-ispytaniya-pervogo-v-rossii-bmkp
Mokhov A.A. Preferential use of medicines under international nonproprietary names in Russian practice: pros and cons. Medical Law. 2014. Vol. 1. Pp. 9-15. (In Rus.)
Olefir Yu.V. Nomenclature of biomedical cell products. Remedium. Magazine about the Russian Market of Medicines and Medical Equipment. 2017. No. 3. Pp. 6-11. (In Rus.)
Solonitsyna L.A., Sazonov S.V., Leontiev S.L. Analysis of the main provisions of Federal Law No. 180-FZ “On biomedical cell products”. Bulletin of the Ural Medical Academic Science. 2017. Vol. 14. No. 1. Pp. 104-110. (In Rus.)
biomedical cell products, international non-proprietary name, legal regulation, biomedical technology market, regulatory framework.